• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外周动脉疾病的药物风险因素管理:血管外科医生手册

Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.

作者信息

Rehring Thomas F, Stolcpart Ryan S, Hollis H Whitton

机构信息

Division of Vascular and Endovascular Surgery, Department of Vascular Therapy, Colorado Permanente Medical Group, Denver, CO 80205, USA.

出版信息

J Vasc Surg. 2008 May;47(5):1108-15. doi: 10.1016/j.jvs.2007.12.033. Epub 2008 Apr 18.

DOI:10.1016/j.jvs.2007.12.033
PMID:18372155
Abstract

There is broad and compelling evidence for risk factor reduction to limit cardiovascular morbidity and mortality in patients with peripheral arterial disease. Indeed, vascular surgeons have placed a call to arms to ensure this takes place. Despite this fact, some wariness exists on the part of many vascular surgeons to initiate these strategies, functionally abnegating their responsibilities in this regard. The purpose of this article is to provide a simple reference to guide effective therapies for overall cardiovascular risk reduction in patients with peripheral arterial disease. Specific recommendations are made for tobacco cessation, lipid-lowering therapy, antiplatelet therapy, blood pressure control, and maintenance of normoglycemia.

摘要

有广泛且令人信服的证据表明,降低危险因素可减少外周动脉疾病患者的心血管发病率和死亡率。事实上,血管外科医生已发出行动呼吁,以确保这一目标得以实现。尽管如此,许多血管外科医生在启动这些策略时仍存在一些顾虑,实际上在这方面放弃了他们的责任。本文的目的是提供一个简单的参考,以指导有效治疗外周动脉疾病患者以降低整体心血管风险。针对戒烟、降脂治疗、抗血小板治疗、血压控制和维持血糖正常提出了具体建议。

相似文献

1
Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.外周动脉疾病的药物风险因素管理:血管外科医生手册
J Vasc Surg. 2008 May;47(5):1108-15. doi: 10.1016/j.jvs.2007.12.033. Epub 2008 Apr 18.
2
Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".关于“外周动脉疾病的药理学危险因素管理:血管外科医生手册”。
J Vasc Surg. 2008 Sep;48(3):776-7; author reply 777. doi: 10.1016/j.jvs.2008.04.074.
3
Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.外周动脉疾病的药物风险因素治疗尚不完善,需要血管外科医生的参与。
Ann Vasc Surg. 2007 Mar;21(2):163-6. doi: 10.1016/j.avsg.2007.01.008.
4
Contemporary and optimal medical management of peripheral arterial disease.外周动脉疾病的当代最佳医学管理。
Surg Clin North Am. 2013 Aug;93(4):761-78, vii. doi: 10.1016/j.suc.2013.04.009. Epub 2013 Jun 18.
5
Optimal medical management of peripheral arterial disease.外周动脉疾病的优化医疗管理
Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. doi: 10.1177/1538574406291835.
6
Optimal risk factor modification and medical management of the patient with peripheral arterial disease.外周动脉疾病患者的最佳危险因素修正与药物治疗
Catheter Cardiovasc Interv. 2008 Mar 1;71(4):475-89. doi: 10.1002/ccd.21401.
7
Peripheral arterial disease: a review of disease awareness and management.外周动脉疾病:疾病认知与管理综述
Am J Geriatr Pharmacother. 2006 Dec;4(4):365-79. doi: 10.1016/j.amjopharm.2006.12.006.
8
Medical treatment of peripheral arterial disease and claudication.外周动脉疾病与间歇性跛行的医学治疗。
N Engl J Med. 2001 May 24;344(21):1608-21. doi: 10.1056/NEJM200105243442108.
9
Pharmacologic therapy for peripheral arterial disease and claudication.外周动脉疾病和间歇性跛行的药物治疗
J Vasc Surg. 2002 Dec;36(6):1283-91. doi: 10.1067/mva.2002.129654.
10
[Risk factor control in peripheral arterial disease can be improved. Registry study of secondary prophylactic drug therapy].[外周动脉疾病的危险因素控制可得到改善。二级预防性药物治疗的登记研究]
Lakartidningen. 2010;107(39):2322-5.

引用本文的文献

1
What the primary care provider needs to know for limb salvage.初级保健提供者进行保肢治疗所需了解的内容。
Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4):57-9. doi: 10.14797/mdcj-8-4-57.
2
Predictors of outcome in stable outpatients with peripheral artery disease.外周动脉疾病稳定门诊患者预后的预测因素
Intern Emerg Med. 2014 Feb;9(1):69-77. doi: 10.1007/s11739-012-0854-1. Epub 2012 Sep 29.
3
Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure?
肾素-血管紧张素系统在内膜增生发病机制中的作用:预防静脉移植物失败的治疗潜力?
Ann Vasc Surg. 2012 Nov;26(8):1130-44. doi: 10.1016/j.avsg.2011.12.001. Epub 2012 Mar 22.
4
The novel association of the chemokine CCL22 with abdominal aortic aneurysm.趋化因子 CCL22 与腹主动脉瘤的新关联。
Am J Pathol. 2010 May;176(5):2098-106. doi: 10.2353/ajpath.2010.090416. Epub 2010 Mar 26.